Jorma Keski-Oja

    M.D., Ph.D., Professor

    Translational Cancer Biology Research Program
    Haartman Institute
    Biomedicum Helsinki

    P.O. Box 63 (Haartmaninkatu 8)
    FI-00014 University of Helsinki
    Finland

    Tel. +358 2 941 25566
    Fax +358 2 941 25610

    firstname.surname@helsinki.fi

    Secretary Merja Koivulahti

Affiliations

Alma-intranet Flammaintra

Transforming Growth Factor Beta in Cancer

Keski-Oja Group

Interplay mechanism between NTN4 and ITGB4 during glioma progression. At the initial stage of glioma progression, NTN4 concentration stays relatively high in extracellular environment. High concentrations of NTN4 have an ability to reduce cell proliferation through UNC5B. During progression, glioma cells reduce NTN4 expression to prevent the negative effects on glioma cell growth induced by NTN4. In parallel, ITGB4 expression increases. In this way, excessive ITGB4 makes glioblastoma cells hyperresponsive to low concentrations of NTN4 for keeping AKT/mTOR phosphorylation and glioma cell proliferation.

Hu, Y., Ylivinkka, I., Chen, P., Li, L., Hautaniemi, S., Nyman, TA., Keski-Oja, J. and Hyytiäinen, M.* (2012) Netrin-4 promotes glioblastoma cell proliferation through integrin beta4 signalling. Neoplasia 14(3):219-227.